[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:solid-organ-transplantation":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":28,"states":29},"Solid Organ Transplantation",3,[7,15,22],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT04691622","Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts",[11],"Phase 1","RECRUITING","2026-08-26T02:18:59.761994Z","2026-05-05T02:43:27.626595Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT03665675","Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT",[19],"Early Phase 1","2026-08-26T02:18:51.009190Z","2026-05-05T02:43:26.962006Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT01163578","Biomarkers in Transplant Recipients to Improve Outcomes",[],"2026-08-26T02:15:28.524219Z","2026-05-13T02:55:06.068415Z",[],[]]